Table 4 2D echocardiographic measurements
From: Hyperinsulinemia improves ischemic LV function in insulin resistant subjects
Echocardiographic variables | Insulin Sensitive | Insulin Resistant | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Control | Clamp | p | Control | Clamp | p | ||||
Pre-DSE | EDV (ml) | 102 | (16) | 99.2 | (19) | ns | 108 | (24) | 103 | (27) | ns |
| Â | ESV (ml) | 38.6 | (7) | 36 | (9) | ns | 40.1 | (13) | 37.5 | (13) | ns |
| Â | SV (ml) | 63.6 | (11) | 63.2 | (13) | ns | 68 | (15) | 65.4 | (15) | ns |
| Â | CO (L/min) | 3.7 | (0.4) | 3.6 | (.7) | ns | 4.2 | (1.1) | 4 | (1.1) | ns |
| Â | EF (%) | 62.2 | (4) | 63.8 | (4.5) | ns | 63.3 | (6) | 64.3 | (5.9) | ns |
Peak | EDV (ml) | 74.9 | (14) | 74.8 | (16) | ns | 86.1 | (22) | 93.3 | (28) | ns |
| Â | ESV (ml) | 26.4 | (9) | 22.1 | (7) | 0.09 | 31.3 | (14) | 25.4 | (11) | 0.03 |
| Â | SV (ml) | 48.5 | (8) | 52.6 | (12) | ns | 54.8 | (11) | 68 | (19) | 0.003 |
| Â | CO (L/min) | 6.3 | (1.4) | 6.8 | (1.7) | ns | 6.9 | (1.5) | 8.3 | (2.1) | 0.001 |
| Â | EF (%) | 65.2 | (6.1) | 70.4 | (6.3) | 0.002 | 64.8 | (7.2) | 73.5 | (5.8) | < 0.0001 |
Recovery | EDV (ml) | 92.2 | (21) | 98.7 | (21) | ns | 103 | (24) | 104 | (23) | ns |
| Â | ESV (ml) | 35.5 | (11) | 39 | (11) | ns | 40.5 | (15) | 35.8 | (13) | 0.09 |
| Â | SV (ml) | 56.6 | (13) | 58.7 | (12) | ns | 62 | (12) | 68 | (12) | 0.05 |
| Â | CO (L/min) | 4.4 | (0.8) | 4.7 | (0.8) | ns | 4.7 | (0.8) | 5 | (1) | ns |
| Â | EF (%) | 61.8 | (5.9) | 60.4 | (4.5) | ns | 61.5 | (7.5) | 66.4 | (6.7) | 0.03 |